We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
-2.99%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$1.7B
AUM Growth
-$507M
Cap. Flow
-$382M
Cap. Flow %
-22.43%
Top 10 Hldgs %
66.15%
Holding
139
New
17
Increased
28
Reduced
53
Closed
24

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$25.8M
2
NICE icon
Nice
NICE
+$21M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$18.3M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$16.6M
5
SLB icon
SLB Ltd
SLB
+$13.6M

Top Sells

Rank Stock Value
1
CCJ icon
Cameco
CCJ
+$102M
2
ZTO icon
ZTO Express
ZTO
+$77M
3
PDD icon
Pinduoduo
PDD
+$68.4M
4
MCHP icon
Microchip Technology
MCHP
+$57.6M
5
TCOM icon
Trip.com Group
TCOM
+$51.3M

Sector Composition

Rank Sector Weight
1 Financials 19.1%
2 Technology 16.24%
3 Industrials 13.83%
4 Communication Services 13.45%
5 Energy 13.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HTHT icon
26
Huazhu Hotels Group
HTHT
$13B
$8.2M 0.48%
248,238
-37,915
-13% -$1.37M
AS icon
27
Amer Sports
AS
$21.4B
$6.99M 0.41%
250,000
-50,000
-17% -$1.1M
ZTS icon
28
Zoetis
ZTS
$30B
$6.52M 0.38%
40,000
– –
ROIV icon
29
Roivant Sciences
ROIV
$26.2B
$6.25M 0.37%
528,031
– –
CNTA
30
DELISTED
Centessa Pharmaceuticals
CNTA
$6.2M 0.36%
370,278
-59,423
-14% -$984K
JNJ icon
31
Johnson & Johnson
JNJ
$625B
$5.2M 0.31%
35,942
– –
PYPL icon
32
PayPal
PYPL
$50.5B
$5.12M 0.3%
60,000
+58,686
+4,466% +$4.93M
BIRK icon
33
Birkenstock
BIRK
$7.07B
$5.1M 0.3%
90,000
– –
VERA icon
34
Vera Therapeutics
VERA
$2.36B
$5.06M 0.3%
119,664
-17,725
-13% -$785K
IMVT icon
35
Immunovant
IMVT
$8.25B
$5.01M 0.29%
202,323
+10,081
+5% +$286K
CSGP icon
36
CoStar Group
CSGP
$12.3B
$5.01M 0.29%
70,000
+20,000
+40% +$1.51M
RXRX icon
37
Recursion Pharmaceuticals
RXRX
$1.73B
$4.96M 0.29%
733,011
+546,929
+294% +$3.68M
ELF icon
38
e.l.f. Beauty
ELF
$5.81B
$4.68M 0.28%
+37,300
New +$4.47M
ZYME icon
39
Zymeworks
ZYME
$1.67B
$4.49M 0.26%
306,460
-21,062
-6% -$295K
AAPL icon
40
Apple
AAPL
$4.57T
$4.38M 0.26%
17,500
-2,500
-13% -$589K
APGE icon
41
Apogee Therapeutics
APGE
$10.2B
$4.33M 0.25%
95,646
-12,048
-11% -$614K
BCYC
42
Bicycle Therapeutics
BCYC
$292M
$4.33M 0.25%
309,059
+36,910
+14% +$791K
PRQR icon
43
ProQR Therapeutics
PRQR
$265M
$4.08M 0.24%
+1,538,247
New +$4.88M
IDYA icon
44
IDEAYA Biosciences
IDYA
$3.56B
$3.92M 0.23%
152,713
+7,996
+6% +$226K
WVE icon
45
Wave Life Sciences
WVE
$1.2B
$3.86M 0.23%
311,992
-149,675
-32% -$2M
MSFT icon
46
Microsoft
MSFT
$3.71T
$3.79M 0.22%
8,989
– –
VEEV icon
47
Veeva Systems
VEEV
$37.4B
$3.6M 0.21%
17,119
– –
NFLX icon
48
Netflix
NFLX
$309B
$3.22M 0.19%
36,180
-8,030
-18% -$661K
ADCT icon
49
ADC Therapeutics
ADCT
$144M
$3.21M 0.19%
1,612,556
+168,040
+12% +$440K
MBX
50
MBX Biosciences
MBX
$3.27B
$2.99M 0.18%
162,090
+12,090
+8% +$258K
1
2
3 4 5

Similar funds

LCG
Lisanti Capital Growth New York $397M AUM 178.66% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GPC
Greenstone Partners & Co Larkspur, California $395M AUM 35.56% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Platinum Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, Platinum Investment Management held 139 positions worth $1.7B, down 23% from $2.21B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Platinum Investment Management withdrew a net $382M in Q4 2024, closing 24 positions and reducing 53 holdings. Its most notable exit was Microchip Technology, an estimated $57.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

Against the trend, Platinum Investment Management opened a new position in ProQR Therapeutics worth $4.08M.

  • Platinum Investment Management's largest Q4 2024 buy was ProQR Therapeutics: 1,538,247 shares worth $4.08M.
  • Platinum Investment Management added most to Broadcom in Q4 2024, an estimated $25.8M increase.
  • Platinum Investment Management's biggest Q4 2024 reduction was Cameco, cutting an estimated $102M.
  • Platinum Investment Management fully exited Microchip Technology in Q4 2024, selling an estimated $57.6M.
  • Platinum Investment Management's ten largest holdings make up 66% of its $1.7B portfolio in Q4 2024.
  • Platinum Investment Management opened 17 new positions and closed 24 in Q4 2024.
  • Platinum Investment Management's portfolio value fell 23% quarter-over-quarter to $1.7B.

Based on Platinum Investment Management's 13F filing for Q4 2024, filed 11 Feb 2025.